Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated at Wells Fargo & Company

Equities research analysts at Wells Fargo & Company began coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a report issued on Monday,Benzinga reports. The brokerage set an “overweight” rating and a $28.00 price target on the stock. Wells Fargo & Company‘s price objective points to a potential upside of 19.50% from the company’s current price.

A number of other analysts have also recently weighed in on KMTS. Stifel Nicolaus began coverage on Kestra Medical Technologies in a research report on Monday. They issued a “buy” rating and a $28.00 price target on the stock. Piper Sandler initiated coverage on shares of Kestra Medical Technologies in a report on Monday. They issued an “overweight” rating and a $27.00 target price on the stock. Finally, The Goldman Sachs Group assumed coverage on shares of Kestra Medical Technologies in a research report on Monday. They issued a “neutral” rating and a $24.00 price target on the stock.

Kestra Medical Technologies Stock Performance

KMTS stock opened at $23.43 on Monday. Kestra Medical Technologies has a 1-year low of $20.00 and a 1-year high of $25.98.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.